Clinical trials, consensus conferences, and clinical practice
- 1 July 1999
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 354 (9175), 327-330
- https://doi.org/10.1016/s0140-6736(98)11185-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The philosophical limits of evidence-based medicineAcademic Medicine, 1998
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Medicolegal implications of the consensus conference, with special attention to the Fifth Antithrombotic Therapy Consensus Conference.Chest, 1998
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)Circulation, 1998
- Conflict of Interest in the Debate over Calcium-Channel AntagonistsNew England Journal of Medicine, 1998
- Problems in the “Evidence” of “Evidence-Based Medicine”American Journal Of Medicine, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Source of funding and outcome of clinical trialsJournal of General Internal Medicine, 1986